Literature DB >> 10462468

The relationship between QT intervals and mortality in ambulant patients with chronic heart failure. The united kingdom heart failure evaluation and assessment of risk trial (UK-HEART)

P Brooksby1, P D Batin, J Nolan, S J Lindsay, R Andrews, M Mullen, W Baig, A D Flapan, R J Prescott, J M Neilson, A J Cowley, K A Fox.   

Abstract

AIMS: Mortality in patients with heart failure remains high and is difficult to predict. QT interval parameters on a 12-lead ECG have been shown to predict arrhythmic events in patients with a variety of myocardial diseases. There is some, but not consistent, evidence that QT interval parameters may act as predictors of mortality, in particular sudden death, in patients with heart failure. In an adequately powered prospective study we have studied QT interval parameters in patients with stable chronic heart failure in order to determine whether they are predictive of all-cause mortality or mode of death. METHODS AND
RESULTS: Five hundred and fifty-four ambulant outpatients with chronic heart failure were recruited. A 12-lead ECG, chest radiograph, echocardiogram, 24 h ambulatory electrocardiogram and serum for biochemical analysis were obtained at baseline. Patients were followed for 471+/-168 days. QT intervals were measured in all leads blinded to patient's characteristics and outcome, were corrected for heart rate, and the maximum QT intervals, and QT dispersion (range of QT intervals) were determined. The same parameters were determined for JT intervals. The primary end-point was all-cause mortality, secondary end-points were sudden cardiac death and death due to progressive heart failure. Multivariate analysis with the Cox's proportional hazards model was used to determine which variables were independently related to outcome. Four hundred and ninety-five patients had analysable ECGs at study entry and of these 71 died during follow-up. The heart rate corrected QT dispersion and maximum QT interval were significant univariate predictors of all-cause mortality (P=0.026 and <0.0001 respectively), and also of sudden death and progressive heart failure death, but were not related to outcome in the multivariate analysis. The independent predictors of all-cause mortality were cardiothoracic ratio (P=0.0003), creatinine (P=0.0009), heart rate (P=0.007), echocardiographically derived left ventricular end-diastolic dimension (P=0.007) and ventricular couplets on 24 h electrocardiographic monitoring (P=0.015).
CONCLUSION: In an adequately powered prospective study none of the QT or JT parameters were shown to be independent predictors of outcome in patients with mild to moderate congestive heart failure. These variables do not therefore add to the prognostic information which can be gained from simple radiographic, biochemical, echocardiographic and Holter data in this group of patients. Copyright 1999 The European Society of Cardiology.

Entities:  

Mesh:

Year:  1999        PMID: 10462468     DOI: 10.1053/euhj.1999.1542

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  17 in total

1.  Relation between severity of left ventricular systolic dysfunction and repolarisation abnormalities on the surface ECG: a report from the Euro heart failure survey.

Authors:  P Velavan; N K Khan; A S Rigby; K Goode; M Komajda; F Follath; K Swedberg; H Madeira; A L Clark; J G F Cleland
Journal:  Heart       Date:  2006-02       Impact factor: 5.994

2.  QRS and QTc interval prolongation in the prediction of long-term mortality of patients with acute destabilised heart failure.

Authors:  Tobias Breidthardt; Michael Christ; Miriam Matti; Delia Schrafl; Kirsten Laule; Markus Noveanu; Tujana Boldanova; Theresia Klima; Willibald Hochholzer; André P Perruchoud; Christian Mueller
Journal:  Heart       Date:  2007-03-29       Impact factor: 5.994

Review 3.  Autonomic effects of spironolactone and MR blockers in heart failure.

Authors:  Justine I Davies; Miles D Witham; Allan D Struthers
Journal:  Heart Fail Rev       Date:  2005-01       Impact factor: 4.214

4.  Quantitative electrocardiographic measures, neuromuscular disorders, and survival in left ventricular hypertrabeculation/noncompaction.

Authors:  Claudia Stöllberger; Daniel Gerger; Christian Wegner; Josef Finsterer
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-05       Impact factor: 1.468

5.  QT intervals and QT dispersion determined from a 12-lead 24-hour Holter recording in patients with coronary artery disease and patients with heart failure.

Authors:  Stig Hansen; Verner Rasmussen; Christian Torp-Pedersen; Gorm Boje Jensen
Journal:  Ann Noninvasive Electrocardiol       Date:  2008-01       Impact factor: 1.468

6.  Drug-sensitized zebrafish screen identifies multiple genes, including GINS3, as regulators of myocardial repolarization.

Authors:  David J Milan; Albert M Kim; Jeffrey R Winterfield; Ian L Jones; Arne Pfeufer; Serena Sanna; Dan E Arking; Adam H Amsterdam; Khaled M Sabeh; John D Mably; David S Rosenbaum; Randall T Peterson; Aravinda Chakravarti; Stefan Kääb; Dan M Roden; Calum A MacRae
Journal:  Circulation       Date:  2009-08-03       Impact factor: 29.690

7.  Predicting sudden death in patients with mild to moderate chronic heart failure.

Authors:  M T Kearney; K A A Fox; A J Lee; W P Brooksby; A M Shah; A Flapan; R J Prescott; R Andrews; P D Batin; D L Eckberg; N Gall; A G Zaman; H S Lindsay; J Nolan
Journal:  Heart       Date:  2004-10       Impact factor: 5.994

Review 8.  Prevalence and incidence of arrhythmias and sudden death in heart failure.

Authors:  John G F Cleland; Sudipta Chattopadhyay; Aleem Khand; Timothy Houghton; Gerald C Kaye
Journal:  Heart Fail Rev       Date:  2002-07       Impact factor: 4.214

9.  Effects of carvedilol therapy on QT-interval dispersion in congestive heart failure: is there a difference in the elderly?

Authors:  Ricardo Mourilhe Rocha; Guilherme Vienna Silva; Emerson C Perin; André Regazzi Gerk; Ellas Pimentel Gouvea; Valéria Martin Soares Santos; Francisco Manes Albanesi Filho; Denilson Campos de Albuquerque
Journal:  Tex Heart Inst J       Date:  2003

10.  Evaluation of biomarkers for cardiotoxicity of anthracyclin-based chemotherapy.

Authors:  F J F Broeyer; S Osanto; H J Ritsema van Eck; A Q M J van Steijn; B E P B Ballieux; R C Schoemaker; A F Cohen; J Burggraaf
Journal:  J Cancer Res Clin Oncol       Date:  2008-03-15       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.